Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid pharmacokinetics/pharmacodynamics in late-onset ventilator-associated pneumonia: intermittent versus continuous infusion
2010-023683-41Phase 4Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of linezolid in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Pharmacokinetics. Started Dec 2010; status: terminated.
02
Drugs
linezolid
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on 2010-023683-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023683-41.